Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age.
Previous studies indicate that the menstrual cycles of older reproductive age women are characterized by a selective elevation of FSH associated with early development and ovulation of a dominant follicle. Several intraovarian hormones and growth factors have been identified that appear to serve important paracrine roles. The purpose of this study was to examine follicular fluid (FF) hormones and growth factors in the dominant follicle of unstimulated cycles of older, ovulatory women. We aspirated FF from the preovulatory dominant follicle in natural menstrual cycles of older subjects (age, 40-45 yr; n = 20) and younger controls (age, 20-25 yr; n = 19). FF was analyzed for estradiol, progesterone, testosterone, androstenedione, inhibin A and B, total activin A, total follistatin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor (VEGF) concentrations. We found that the dominant follicles from older women contain normal concentrations of steroids, inhibin A and B, IGF-II, IGFBP-2, and IGFBP-3; increased concentrations of follistatin, activin A, and VEGF; and decreased concentrations of IGF-I. Therefore, under the influence of elevated FSH, the dominant follicle in older women is highly competent in terms of hormone and growth factor secretion. We postulate that elevated FF activin may be related to the early ovulation observed in older women, whereas elevated VEGF may be related to the meiotic spindle abnormalities observed in the oocytes of older reproductive age women.
Klein
N A
NA
University of Washington, Seattle, Washington 98105, USA. nklein@u.washington.edu
Battaglia
D E
DE
Woodruff
T K
TK
Padmanabhan
V
V
Giudice
L C
LC
Bremner
W J
WJ
Soules
M R
MR
D028341:Activins; D000328:Adult; D000375:Aging / Q000378:metabolism*; D015153:Blotting, Western; D016228:Endothelial Growth Factors / Q000378:metabolism; D005260:Female; D038681:Follistatin; D006023:Glycoproteins / Q000378:metabolism; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism; D006728:Hormones / Q000097:blood*; D006801:Humans; D007265:Inhibins / Q000378:metabolism; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000378:metabolism; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D008222:Lymphokines / Q000378:metabolism; D008597:Menstrual Cycle / Q000378:metabolism*; D006080:Ovarian Follicle / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D038681:Follistatin; D006023:Glycoproteins; D012739:Gonadal Steroid Hormones; D006133:Growth Substances; D006728:Hormones; D018971:Insulin-Like Growth Factor Binding Protein 2; D018972:Insulin-Like Growth Factor Binding Protein 3; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D028341:Activins; D007265:Inhibins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II